Allstocks.com's Bulletin Board Post New Topic  New Poll  Post A Reply
my profile login | register | search | faq | forum home

  next oldest topic   next newest topic
» Allstocks.com's Bulletin Board » Hot Stocks Free for All ! » TPIV analysts say $1.50 coming! Check it out:

 - UBBFriend: Email this page to someone!    
Author Topic: TPIV analysts say $1.50 coming! Check it out:
flatrader
Member


Rate Member
Icon 1 posted      Profile for flatrader     Send New Private Message       Edit/Delete Post   Reply With Quote 
TPIV analysts say $1.50 coming! Check it out:

Tapimmune expects to sign up multiple partnerships for technology development and commercialization in large markets because “our technology has the potential to improve a variety of other technologies and approaches
in the treatment of breast cancer and other infectious diseases, says Dr. Wilson. The company, he adds, expects to become a market leader in biotechnology “as we expect our continuing research to yield a pipeline of products.

Apart from a potential to make substantial returns from their investments, investors in the company should get the satisfaction that “their money would be directed to technologies which could alleviate pain and suffering caused by both the diseases and existing treatments.”


"When Tapimmune is recognized as an immunotherapy play along with the likes of Northwest BioTherapeutics (NWBO) and ImmunoCellular Therapeutics (IMUC), the market cap of Tapimmune is expected by some analysts to hit a market cap of $100 million, or a stock price of $1.50......"

Posts: 195 | From: Florida | Registered: Feb 2010  |  IP: Logged | Report this post to a Moderator
   

Quick Reply
Message:

HTML is not enabled.
UBB Code™ is enabled.

Instant Graemlins
   


Post New Topic  New Poll  Post A Reply Close Topic   Feature Topic   Move Topic   Delete Topic next oldest topic   next newest topic
 - Printer-friendly view of this topic
Hop To:


Contact Us | Allstocks.com Message Board Home

© 1997 - 2013 Allstocks.com. All rights reserved.

Powered by Infopop Corporation
UBB.classic™ 6.7.2

Share